Ownership history in RENAISSANCE TECHNOLOGIES LLC · 11 quarters on record
This page tracks every 13F SEC filing in which RENAISSANCE TECHNOLOGIES LLC reported a position in CARISMA THERAPEUTICS INC (CARM). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 293,686 | -35,600 | -10.8% | 0.00% | $80K | $0.27 |
| 2025 Q2 | ADDED | 329,286 | +75,629 | +29.8% | 0.00% | $129K | $0.39 |
| 2025 Q1 | ADDED | 253,657 | +22,300 | +9.6% | 0.00% | $79K | $0.31 |
| 2024 Q4 | ADDED | 231,357 | +24,600 | +11.9% | 0.00% | $97K | $0.42 |
| 2024 Q3 | ADDED | 206,757 | +67,397 | +48.4% | 0.00% | $203K | $0.98 |
| 2024 Q2 | REDUCED | 139,360 | -86,635 | -38.3% | 0.00% | $212K | $1.52 |
| 2024 Q1 | ADDED | 225,995 | +12,961 | +6.1% | 0.00% | $513K | $2.27 |
| 2023 Q4 | ADDED | 213,034 | +8,339 | +4.1% | 0.00% | $624K | $2.93 |
| 2023 Q3 | ADDED | 204,695 | +102,935 | +101.2% | 0.00% | $866K | $4.23 |
| 2023 Q2 | ADDED | 101,760 | +33,465 | +49.0% | 0.00% | $892K | $8.77 |
As of 2025 Q4 — sorted by position size